Vicor Q3 Call Highlights AI Demand and Capacity Expansion, but Valuation Keeps Us Cautious

What happened

Vicor's Q3 earnings call emphasized strong AI-driven demand, with management highlighting robust vertical power delivery (VPD) traction and rising licensing revenues. The company also discussed expanded manufacturing capacity, suggesting progress on debottlenecking or a second fab, which addresses a key constraint from the previous report. However, the stock's valuation remains stretched at around $215, trading at 70.9x earnings and 80.9x EV/EBITDA, leaving little margin for execution missteps. While the call's tone is positive, the lack of specific figures in the article means we cannot yet confirm whether royalties exceeded $25 million or backlog held above $350 million. Investors should treat this as encouraging but insufficient; the next step is to verify the durability of royalty revenue and obtain a concrete Fab 2 timeline.

Implication

The positive Q3 commentary reinforces the demand story, yet Vicor's shares already embed significant growth expectations, leaving limited upside unless the company delivers on multiple fronts. Investors should monitor whether royalties remain above $25 million per quarter, backlog stays above $350 million, and management commits to a dated Fab 2 expansion. If those conditions are met and the stock does not surge, it could signal a stronger entry point. Conversely, if the rally has already priced in these positives, the risk of multiple compression rises. A disciplined approach would be to wait for a pullback toward the $175 attractive entry level or for explicit capacity commitments before adding exposure. For now, maintain a wait-and-see stance and focus on the next quarterly disclosure.

Thesis delta

The thesis remains WAIT, but the Q3 call provides incremental support for the AI demand and licensing narrative. If the undisclosed numbers meet the thresholds set in the prior report (royalties >$25M, backlog >$350M), the case for an upgrade strengthens. However, until Fab 2 timing is confirmed and valuation normalizes, we maintain our cautious stance.